NOVT
Novanta Inc.

Novanta Inc.NOVT

Technology · Scientific & Technical Instruments
144.17USD
+7.34%
Sep 23, 2026
NOVT overview ready
Enabler of force/torque sensors and robotic components for humanoid manipulation
Novanta is a multi-product robotics-component enabler rather than a humanoid OEM or pure play.
Narrative is still early
Exposed to the Humanoid Robotics Industrialization narrative through Force, Torque and Tactile Sensing for Humanoid Robots — component supplier.
No clear price read
Longer-term context reads early recovery, with a near-term setup of daily advance.
Demanding valuation
The price embeds expectations that run ahead of what comparable businesses command.
Fundamentals under pressure
Ev / ebitda is weak.
Primary risk
Execution risk related to Riverpoint integration.
Market Sep 22Filing Jul 3Price action Sep 22Research Jul 29

Conviction Level

NarrativeHeat6.7ThemeHeat5.8PriceAction6.0Valuation2.8CompanyPosition9.3
Price
Loading price history…

Price Action

No clear price read
Longer-term context reads early recovery, with a near-term setup of daily advance.
EntryConstructive

Structure is constructive on both timeframes without excessive extension — a reasonable entry location.

Key Financials

Market Cap
$5.5B
Avg Volume (60D)
397.8K
60 sessions
Revenue Growth YoY
+3.3%
FY2025 vs FY2024
Gross Margin
+44.5%
Trailing twelve months
Operating Margin
+9.0%
Trailing twelve months
Free Cash Flow Yield
+2.1%
Distance from 200DMA
+3.5%
Next Earnings
2026-11-03
P/E
88.3x
EV / EBITDA
32.3x
EV / Sales
4.8x
Market metrics as of Sep 22, 2026
Financial results for the period ended Jul 3, 2026
Filed balance-sheet data as of Jul 3, 2026

Fundamentals & Valuation

Two of the three valuation perspectives say expensive; own history is the dissenting view.
Novanta Inc. has an Expensive valuation stance because the price embeds expectations that run ahead of what comparable businesses command. It trades at a 2.1% free-cash-flow yield and 32.3x EBITDA, which require sustained delivery to be justified.

Company Research

Thesis
Novanta is a multi-product robotics-component enabler rather than a humanoid OEM or pure play. It supplies force/torque sensors alongside encoders, frameless motors, servo drives, and end-of-arm technologies that can be designed into humanoid joints, wrists, and manipulation systems.
Opportunity
Moderate opportunity
Commercial deployment of humanoid and other human-collaborative robots increases demand for compact, high-precision force/torque and tactile sensing needed for compliant manipulation, collision detection, dexterous handling, balance, and safe operation around people.
Key risk
Execution risk related to Riverpoint integration.

Narrative & Theme

Humanoid Robotics Industrialization
Part of Force, Torque and Tactile Sensing for Humanoid Robots, with moderate fit.
Novanta’s actual current business is supplying precision technologies to medical, life-science, advanced-industrial, and robotics OEMs: motion systems, encoders, motors, servo drives, force/torque sensors, robotic end-effectors, photonics, and medical/surgical technologies.
Narrative HeatNeutral6.7 / 10
Theme HeatNeutral5.8 / 10
This is the company’s own research reading. The canonical heat measurement for this story has not run.

Business & Markets

Technology · Scientific & Technical Instruments
What they do

Novanta Inc. designs, manufactures, and sells precision laser, motion, and robotic components and systems primarily for medical and advanced industrial applications through its Automation Enabling Technologies and Medical Solutions segments.

How it earns

The company generates revenue primarily through transactional sales of hardware components and integrated systems to industrial and medical customers.

Products & services
Laser beam steering and scanning solutions
Laser sources
Robotic and precision motion components
Robotic end-of-arm tooling
Bearing spindles
Customers & end markets
Medical device manufacturers
Advanced industrial manufacturers
Robotics and automation companies
Market position

Novanta is a specialized provider with a strong position in precision components for medical and industrial automation markets.

Demand drivers
Medium cyclicality

Demand is influenced by capital spending cycles in advanced manufacturing and healthcare technology adoption.